Restasis Sales Data
| Rank 55 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Restasis U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 55 ( 2) |
$268,463 | 6.30% | 1,496 | 3.60% |
| Q3 2013 | 57 (2) |
$252,558 | 1.73% | 1,444 | -4.75% |
| Q2 2013 | 59 (6) |
$248,265 | 4.54% | 1,516 | 1.74% |
| Q1 2013 | 65 | $237,475 | 1.89% | 1,490 | -3.62% |
| Q4 2012 | 65 (7) |
$233,071 | 7.36% | 1,546 | 7.21% |
| Q3 2012 | 72 (3) |
$217,097 | 7.35% | 1,442 | 8.67% |
| Q2 2012 | 75 (11) |
$202,233 | 7.28% | 1,327 | 2.79% |
| Q1 2012 | 86 | $188,501 | -1.18% | 1,291 | -3.73% |
| Q4 2011 | 86 | $190,745 | 8.79% | 1,341 | 4.60% |
| Q3 2011 | 86 (2) |
$175,330 | -2.15% | 1,282 | -1.16% |
| Q2 2011 | 88 (2) |
$179,182 | 1.43% | 1,297 | 0.23% |
| Q1 2011 | 90 | $176,652 | n/a | 1,294 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
